|
LSM6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.65140000025255E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.25759999992337E-07 |
| Normal-vs-Stage2 |
6.115500E-03 |
| Normal-vs-Stage3 |
6.975700E-03 |
| Normal-vs-Stage4 |
1.434680E-04 |
| Stage1-vs-Stage2 |
6.757200E-01 |
| Stage1-vs-Stage3 |
3.945900E-02 |
| Stage1-vs-Stage4 |
5.531800E-01 |
| Stage2-vs-Stage3 |
4.023000E-01 |
| Stage2-vs-Stage4 |
9.885000E-01 |
| Stage3-vs-Stage4 |
2.601600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.47420000008137E-07 |
| Normal-vs-AfricanAmerican |
3.824000E-03 |
| Normal-vs-Asian |
1.300390E-01 |
| Caucasian-vs-AfricanAmerican |
9.218600E-01 |
| Caucasian-vs-Asian |
4.301000E-01 |
| AfricanAmerican-vs-Asian |
5.547800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.50297999998994E-05 |
| Normal-vs-Female |
1.22339999997223E-06 |
| Male-vs-Female |
4.085800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.250200E-02 |
| Normal-vs-Age(41-60Yrs) |
4.6335000000175E-06 |
| Normal-vs-Age(61-80Yrs) |
1.79580000003732E-06 |
| Normal-vs-Age(81-100Yrs) |
4.662300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.569400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.912800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.857800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.836200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.586600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.951200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.821900E-04 |
| Normal-vs-Grade 2 |
1.53760000287662E-08 |
| Normal-vs-Grade 3 |
1.035890E-03 |
| Normal-vs-Grade 4 |
8.115300E-03 |
| Grade 1-vs-Grade 2 |
5.532800E-01 |
| Grade 1-vs-Grade 3 |
4.516400E-02 |
| Grade 1-vs-Grade 4 |
1.362640E-01 |
| Grade 2-vs-Grade 3 |
1.360120E-03 |
| Grade 2-vs-Grade 4 |
5.707800E-02 |
| Grade 3-vs-Grade 4 |
8.346600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.15929973690754E-10 |
| Normal-vs-ccB subtype |
3.724400E-02 |
| ccA subtype-vs-ccB subtype |
2.7338999997184E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.88069000000013E-05 |
| Normal-vs-N1 |
2.315200E-01 |
| N0-vs-N1 |
3.977800E-01 |
|
|
